Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
115.79
-0.07 (-0.06%)
Jan 23, 2025, 9:30 AM EST - Market open
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 58 employees as of December 31, 2023. The number of employees decreased by 18 or -23.68% compared to the previous year.
Employees
58
Change (1Y)
-18
Growth (1Y)
-23.68%
Revenue / Employee
$2,627,966
Profits / Employee
$780,069
Market Cap
2.19B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
LGND News
- 9 days ago - Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025 - Seeking Alpha
- 6 weeks ago - Ligand Hosts 2024 Investor and Analyst Day and Introduces 2025 Guidance - Business Wire
- 2 months ago - Ligand Pharmaceuticals: Buy This Strong Growing Pharma And Get A Stake In Dozens Of Therapies - Seeking Alpha
- 2 months ago - Ligand to Present at Stifel 2024 Healthcare Conference - Business Wire
- 2 months ago - Ligand Pharmaceuticals Incorporated (LGND) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance - Business Wire
- 2 months ago - Ligand to Host Investor and Analyst Day on December 10, 2024 in Boston - Business Wire
- 3 months ago - Ligand to Report Third Quarter 2024 Financial Results on November 7, 2024 - Business Wire